Abdul RahmanAlchakiMD

PubMed

• Rapid expansion of post traumatic syringomyelia following parathyroidectomy: A case report and review of the literature.
  Hunter A O'Connor, Paul F Thanel, Shouri K Dirks, Abdul R Alchaki> ;Surgical Neurology International. 2023 Jan 1
• 5 citations
  Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report.
  Travis Moodie, Ola Alshaqi, Abdul Alchaki> ;BMC Neurology. 2022 Mar 19
• 5 citations
  A Rare Case of Cyclophosphamide-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Anti-GBM Vasculitis, and Review of Current Literature.
  Taha Nisar, Abdul Rahman Alchaki, Erin Feinstein> ;Case Reports in Neurological Medicine. 2019 Sep 29
• 15 citations
  Validation of ICH score in a large urban population.
  Taha Nisar, Abdul Rahman Alchaki, Machteld Hillen> ;Clinical Neurology and Neurosurgery. 2018 Nov 1
• 8 citations
  Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome
  Fawaz Al-Mufti, Vincent Dodson, Ethan Wajswol, Mohammad El-Ghanem, Abdulrahman Alchaki, Rolla Nuoman, Ahmad M. Thabet, Anne Sutherland, Sudipta Roychowdhury, Andrea Hi...> ;British Journal of Neurosurgery. 2018 Sep 12
• Join now to see all

Journal Articles

• Past, Present, and Future  
  Cook SD, Alchaki A. MS, Neurology Reviews, 1/1/2018

Abstracts/Posters

• The Contribution of Medieval Islamic Scholars to the Progress of Neuroscience: Headache.
  Alchaki O, Patel J, Alchaki A, Souayah N, AAN, Los Angeles, CA, 1/1/2018
• Development of Clinically Isolated Syndrome after Vaccination, A CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Study, [19852017].
  Fakher Eddin M, Patel J, Alchaki A, Souayah N, AAN, Los Angeles, CA, 1/1/2018
• Development of Multiple Sclerosis relapse flare after Vaccination, A CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Study, [19872017].
  Fakher Eddin M, Patel J, Alchaki A, Souayah N, AAN, Los Angeles, CA, 1/1/2018
• A rare case of cyclophosphamide induced posterior reversible encephalopathy syndrome PRES.
  Nisar T, Alchaki A, Feinstein E, AAN, Los Angeles, CA, 1/1/2018
• Development of Optic Neuritis after Vaccination, A CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Study, 19902017.
  Patel J, Fakher Eddin M, Alchaki A, Souayah N, AAN, Los Angeles, CA, 1/1/2018
• Development of Transverse Myelitis after Vaccination, A CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Study, 1985-2017.
  Shah S, Fakher Eddin M, Patel J, Alchaki A, Souayah N, AAN, Los Angeles, CA, 1/1/2018
• Efficacy and safety of IV Cladribine in patients with multiple sclerosis.
  Alchaki A, Anadani N, Cook SD, ACTRIMS annual meeting, San Diego, CA, 1/1/2018
• Exploring the worth of CTA for ICHUsefulness of CT Angiography in the Diagnosis and Treatment of Intracranial Hemorrhage.
  Alchaki A, Gomez C, El-Ghanem M, Hillen M, American Academy of Neurology annual meeting, Boston, MA, 1/1/2017
• Fatal case of a thyrotoxic periodic paralysis, presenting as hyperacute ascending paralysis and cardiac arrhythmia.
  Alchaki A, Nisar T, Sugalski G, Hillen M, American Academy of Neurology annual meeting, Boston, MA, 1/1/2017
• Association Between Influenza Vaccination and Development of Guillain-Barre; Syndrome in Adults: A Vaccine Safety Datalink (VSD) and Vaccine Adverse Event Reporting Sy...
  Gomez C, Alchaki A, El-Ghanem M, Abu Nasar, Souayah N, American Academy of Neurology annual meeting, Boston, MA, 1/1/2017
• Unusual initial presentation of Sporadic Creutzfeld Jakob disease as an acute neuropathy.
  Hanumanthu R, Alchaki A, Feinstein E, Movement Disorder Society Congress, Vancouver, Canada, 1/1/2017
• Join now to see all

Lectures

• MS: disease modification therapy 
  Rutgers-NJMS, Newark, NJ - 1/15/2018
• MS: Pathology and Clinical Features 
  Rutgers-NJMS, Newark, NJ - 1/7/2018
• After finishing residency training; Job and Coding 
  Rutgers-NJMS, Newark, NJ - 1/5/2018
• Ischemic stroke management 
  Rutgers-NJMS, Newark, NJ - 1/24/2017
• ICH management 
  Rutgers-NJMS, Newark, NJ - 1/12/2017
• Ocrelizumab in relapsing-remitting multiple sclerosis; a phase III, randomized, placebo-controlled, multicentre trial 
  Rutgers-NJMS, Newark, NJ - 1/25/2016
• MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study 
  Rutgers-NJMS, Newark, NJ - 1/23/2016
• MG that mimics a stroke; patient with acute slurred of speech found to have MG 
  Rutgers-NJMS, Newark, NJ - 1/21/2015
• Bilateral MCA infarcts; patient presented with AMS found to have bilateral MCA strokes secondary to rheumatoid heart disease 
  Rutgers-NJMS, Newark, NJ - 1/12/2015
• Neuromuscular junction disorder MG and ELMG 
  Rutgers-NJMS, Newark, NJ - 1/11/2015
• Cryptococcal meningitis; HIV patient first presented with Cryptococcus meningitis and syphilis 
  Rutgers-NJMS, Newark, NJ - 1/10/2014
• Join now to see all